-
Clinical Trials Are ‘Too Damn Complicated’
Simplifying clinical research is possible and desirable, says Dr John Marshall.
Category: News
-
Sharing Innovation and Motivation at the Ruesch Center Symposium
Nearly 300 medical professionals, patients, caregivers and advocates attended the 8th Annual Ruesch Center Symposium on December 1, listening to lectures on topics including precision medicine, immunotherapy, proton therapy and molecular imaging.
Category: News
-
Addressing an Aching Need to do Something About Pancreatic Cancer
Jeanne Ruesch received the Margaret L. Hodges Leadership Award at the 31st annual Lombardi Gala on November 18 for her advocacy on behalf of research into pancreatic cancer and other cancers of the GI tract.
Category: News
-
Obstacles to Clinical Research
Dr. Marshall discusses the obstacles to global clinical research and how these may be overcome.
Category: News
-
Luminary Awards Honors CEO Julie Fleshman
On Dec. 1, OncLive® and The Ruesch Center for the Cure of Gastrointestinal Cancer, hosted the inaugural Luminary Awards in GI Cancer. Julie Fleshman, JD, MBA, PanCAN president and CEO, was honored at this event as well four other prominent figures in the GI community.
Category: News
-
Dr. Pishvaian Discusses Progress in Pancreatic Cancer
Michael Pishvaian, MD, PhD, director, Phase I Clinical Program, co-director of the Ruesch Center Pancreatic Cancer Program Medical Oncology, Otto J. Ruesch Center for the Cure of GI Cancer, Georgetown University Lombardi Comprehensive Cancer Center, discusses the progress that has been made in the treatment of patients with pancreatic cancer during the 2017 Ruesch Center Symposium.
Category: News
-
Dr. Marshall Discusses the State of RAS Mutations in GI Cancers
John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, discusses the current state of RAS-mutant gastrointestinal (GI) cancers during the 2017 Ruesch Center Symposium.
Category: News
-
Luminary Awards Reignite Commitment to Ending GI Cancers
Five leaders in the fight against gastrointestinal (GI) cancers from academia, the community, and clinic were honored last night at the inaugural Luminary Awards.
Category: News
-
Dr. Marshall on the Luminary Awards in GI Cancers
John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, discusses the first annual Luminary Awards in GI Cancers, which is honoring five individuals who have devoted their time, talent and resources to improving the care for patients and families affected by GI cancers.
Category: News
-
Dr. Henry Lynch to be honored again for his cancer research
In December, Dr. Henry Lynch will be honored again for his work by the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C.
Category: News